Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.
Nuveen International Dividend Growth C NUICX
- NAV / 1-Day Return 28.16 / +0.21 %
- Total Assets 5.2 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.890%
- Distribution Fee Level Average
- Share Class Type Level Load
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 3,000
- Status Open
- TTM Yield 1.63%
- Turnover 20%
USD | NAV as of Apr 25, 2024 | 1-Day Return as of Apr 25, 2024, 10:14 PM GMT+0
Morningstar’s Analysis NUICX
Will NUICX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 42.4
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
BAE Systems PLC | 4.87 | 260,795 | Industrials |
Novo Nordisk A/S Class B | 4.83 | 258,343 | Healthcare |
ITOCHU Corp | 4.73 | 253,462 | Industrials |
Linde PLC | 4.34 | 232,160 | Basic Materials |
Taiwan Semiconductor Manufacturing Co Ltd ADR | 4.29 | 229,788 | Technology |
SAP SE | 4.28 | 228,989 | Technology |
Lvmh Moet Hennessy Louis Vuitton SE | 3.90 | 208,753 | Consumer Cyclical |
Sanofi SA | 3.85 | 205,854 | Healthcare |
Hikma Pharmaceuticals PLC | 3.75 | 200,688 | Healthcare |
Macquarie Group Ltd | 3.55 | 189,913 | Financial Services |